Prenatal Blood Screening Study*

Help us advance Non-invasive Prenatal Screening

We are currently seeking pregnant women aged 18 years and older in the early stages of pregnancy, specifically between 7-13 weeks. This innovative study aims to advance cell-based noninvasive prenatal screening (cbNIPS) by isolating fetal cells from a simple blood draw, providing valuable insights into the baby’s genetic composition. As a token of appreciation, participants accepted by BioFluidica will receive compensation of $100 and an optional gender reveal result for their invaluable contribution to this research study. We also offer mobile service collection and can come to you!

For questions and more information please email us at: ClinicalOps@biofluidica.com